Evidence-based recommendations on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. This involves placing a device under the skin of the chest, which detects and treats fast heartbeats called tachyarrhythmias.

Is this guidance up to date?

Next review: this guidance will be reviewed if there is new evidence or safety concerns.

Guidance development process

How we develop NICE interventional procedures guidance

Coding and clinical classification codes for this guidance

This guidance replaces NICE interventional procedures guidance on insertion of a subcutaneous implantable cardioverter defibrillator for prevention of sudden cardiac death (IPG454).

  • National Institute for Health and Care Excellence (NICE)